Skip to content
★ Sign in to follow
VV

Vittal Vasista

Chief Financial Officer
Total declarations
112
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (83 ops.)
€16.5M

Latest filing published 21 Mar 2024 for REGENXBIO Inc., €69k.

Filing timeline

BuySale
Vittal Vasista

Insider track record

Disclosed buys
0
Disclosed sells
83
Signal history

Vittal Vasista: trading record in brief

Vittal Vasista, listed as finance chief, appears in our data through filings on REGENXBIO Inc. shares, published by SEC (Form 4). Between 22 September 2015 and 19 March 2024, the trades on record add up to 112 filings.

No open-market purchase appears, only 83 sales worth €16.5M. Outside the open market, there are 8 share grants and 20 option exercises.

The newest entry dates from 21 March 2024: an option exercise of €69k, in REGENXBIO Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Vittal Vasista

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations112 total
  • ◇
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    75,354 USD20SEC
    20,041 shares@ US$3.7613.4% of flowCommon StockSEC:0001562180-24-002907:0
  • ◆
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    0SEC
    16,026 shares0Common StockSEC:0001562180-24-000246:1
  • ◆
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    81,385 USD20SEC
    4,534 shares@ US$17.9514.2% of flowCommon StockSEC:0001562180-24-000246:0
  • ◇
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    29,750 USD20SEC
    35,000 shares@ US$0.855.4% of flowCommon StockSEC:0001562180-23-004722:0
  • ◆
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    0SEC
    46,174 shares0Common StockSEC:0001562180-23-000224:1
  • ◆
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    30,232 USD20SEC
    1,333 shares@ US$22.685.5% of flowCommon StockSEC:0001562180-23-000224:0
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    72,573 USD20SEC
    2,400 shares@ US$30.238614.0% of flowCommon StockSEC:0001562180-22-006398:0
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    608,083 USD19SEC
    17,280 shares@ US$35.193.3% of flowCommon StockSEC:0001562180-22-005938:1
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    14,000 USD19SEC
    400 shares@ US$35.002.6% of flowCommon StockSEC:0001562180-22-005938:0
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    75,012 USD20SEC
    2,400 shares@ US$31.25514.1% of flowCommon StockSEC:0001562180-22-005876:0
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    14,040 USD19SEC
    468 shares@ US$30.000.1% of flowCommon StockSEC:0001562180-22-005681:1
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    129,988 USD22SEC
    4,332 shares@ US$30.006525.0% of flowCommon StockSEC:0001562180-22-005681:0
  • ◇
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    25,415 USD19SEC
    29,900 shares@ US$0.854.3% of flowCommon StockSEC:0001562180-22-000597:0
  • ◆
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    0SEC
    8,900 shares0Common StockSEC:0001562180-22-000170:0
  • ◇
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    8,500 USD19SEC
    10,000 shares@ US$0.851.4% of flowCommon StockSEC:0001562180-21-005088:0
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    12,610 USD37SEC
    252 shares@ US$50.040.1% of flowCommon StockSEC:0001562180-21-000379:0
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    210,042 USD37SEC
    4,200 shares@ US$50.011.0% of flowCommon StockSEC:0001562180-21-000344:0
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    554,983 USD37SEC
    11,093 shares@ US$50.032.6% of flowCommon StockSEC:0001562180-21-000344:1
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    549,900 USD34SEC
    10,998 shares@ US$50.002.6% of flowCommon StockSEC:0001562180-21-000283:0
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    114,267 USD34SEC
    2,460 shares@ US$46.450.5% of flowCommon StockSEC:0001562180-21-000283:1
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    27,590 USD34SEC
    573 shares@ US$48.150.1% of flowCommon StockSEC:0001562180-21-000283:3
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    104,858 USD34SEC
    2,208 shares@ US$47.490.5% of flowCommon StockSEC:0001562180-21-000283:2
  • ◆
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    0SEC
    12,400 shares0Common StockSEC:0001562180-21-000144:0
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    1M USD33SEC
    21,124 shares@ US$50.0116.0% of flowCommon StockSEC:0001562180-20-007470:0
  • ▼
    Chief Financial OfficerExecutivesREGENXBIO Inc.
    168,800 USD31SEC
    3,376 shares@ US$50.002.5% of flowCommon StockSEC:0001562180-20-007470:1

25 of 112 declarations